Logo image of CANF

CAN FITE BIOPHARMA LTD-ADR (CANF) Stock Analyst Ratings

USA - NYSE Arca - NYSEARCA:CANF - US13471N3008 - ADR

4.36 USD
-0.35 (-7.43%)
Last: 1/8/2026, 8:04:00 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CANF. The Buy consensus is the weighted average rating of the current analysts ratings.

CANF was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CANF.
In the previous month the buy percentage consensus was at a similar level.
CANF was analyzed by 7 analysts. More opinions would make the average more meaningful.
CANF Historical Analyst RatingsCANF Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6
CANF Current Analyst RatingCANF Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-12-17 D. Boral Capital Maintains Buy -> Buy
2025-11-18 D. Boral Capital Maintains Buy -> Buy
2025-09-16 D. Boral Capital Maintains Buy -> Buy
2025-09-02 D. Boral Capital Maintains Buy -> Buy
2025-07-29 D. Boral Capital Maintains Buy -> Buy
2025-04-15 D. Boral Capital Maintains Buy -> Buy
2025-03-21 D. Boral Capital Maintains Buy -> Buy
2025-03-20 D. Boral Capital Maintains Buy -> Buy
2025-03-18 D. Boral Capital Maintains Buy -> Buy
2025-03-03 D. Boral Capital Maintains Buy -> Buy
2025-02-18 D. Boral Capital Maintains Buy -> Buy
2024-12-31 D. Boral Capital Maintains Buy -> Buy
2024-12-05 D. Boral Capital Maintains Buy -> Buy
2024-11-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-10 EF Hutton Maintains Buy -> Buy
2024-09-24 EF Hutton Maintains Buy -> Buy
2024-08-30 EF Hutton Maintains Buy -> Buy
2024-07-17 EF Hutton Initiate Buy
2024-05-09 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-24 HC Wainwright & Co. Maintains Buy -> Buy
2023-06-02 HC Wainwright & Co. Reiterate Buy
2023-03-13 HC Wainwright & Co. Reiterate Buy

CAN FITE BIOPHARMA LTD-ADR / CANF FAQ

How do analysts rate CAN FITE BIOPHARMA LTD-ADR (CANF)?

The consensus rating for CAN FITE BIOPHARMA LTD-ADR (CANF) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.